Menu Content
Research Consortium member David Holtzman featured in US News and World Report

A US News and World Report article profiles a new test to determine the effectiveness of Alzheimer's drugs developed by Cure Alzheimer's Fund's Dr. David Holtzman. The stable isotope-linked kinetics or SILK test quickly reveals whether medication is working to limit the harmful protein amyloid beta. 

Click here to read full article

 
Rock Stars of Science Website goes Live
ImageRock stars and researchers, including Cure Alzheimer’s Fund’s Sam Gandy and Rudy Tanzi, shared the spotlight in the June GQ magazine. Now the related website is live with expanded interviews and photos. Learn more about the how scientists and rock stars are working together to accelerate cures for our most threatening diseases.

Rock Stars of Science website>
Page about Dr. Rudy Tanzi>
Page about Dr. Sam Gandy>
 
Co-Founder McCance discusses Cure Alzheimer's Fund in Harvard Business Review

Cure Alzheimer's Fund co-founder Henry McCance is interviewed about the success of the Fund in applying a venture capital approach to support groundbreaking Alzheimer's research. The profile of Henry and Cure Alzheimer's Fund is by venture capitalist and HBR contributor Tony Tjan.

Click here to read more

 
Wall Street Journal column features Cure Alzheimer's Fund's Armour

Wall Street Journal column on the impact of the economic downturn on charities quotes Cure Alzheimer's Fund President Tim Armour on the Fund's success of moving funds as quickly as possible to research rather than establishing an endowment. Armour participated on a panel at the Boston College Center on Wealth and Philanthropy Conference.

Click here to read the column